|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Gemfibrozil#Contraindications]] |
| {{Gemfibrozil}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Contraindications==
| |
| | |
| 1.Hepatic or severe [[renal dysfunction]], including [[primary biliary cirrhosis]].
| |
| 2.Preexisting gallbladder disease (see WARNINGS).
| |
| 3.[[Hypersensitivity]] to gemfibrozil.
| |
| 4.Combination therapy of gemfibrozil with [[repaglinide]] (see PRECAUTIONS).
| |
| 5.Combination therapy of gemfibrozil with [[simvastatin]] (see WARNINGS and PRECAUTIONS).<ref>{{Cite web | last = | first = | title = DailyMed: Search | url = http://dailymed.nlm.nih.gov/dailymed/search.cfm?startswith=+Lopid&x=11&y=10 | publisher = | date = | accessdate = 13 February 2014 }}</ref>
| |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
|
| |
|
| | [[Category: Cardiovascular Drugs]] |
| | [[Category: Drug]] |
| [[Category:Fibrates]] | | [[Category:Fibrates]] |
| [[Category:Phenol ethers]]
| |
| [[Category:Cardiovascular Drug]]
| |
| [[Category:Drug]]
| |